BRIEF-AB Science announces new U.S. patent for masitinib in treatment of asthma

* Announces issuance of a new U.S. patent for masitinib in the treatment of severe persistent asthma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.